x
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF
1934
|
o
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF
1934
|
For the transition period from ______ to ______ | |
Commission file number: 001-33059 |
Delaware
|
20-5657551
|
(State
or other jurisdiction of incorporation of organization)
|
(I.R.S.
Employer Identification Number)
|
Page
|
||
PART
I.
|
FINANCIAL
INFORMATION
|
|
Item
1.
|
Financial
Statements (Unaudited)
|
|
Condensed
Consolidated Balance Sheets as of March 31, 2008 and December 31,
2007
|
1
|
|
Condensed
Consolidated Statements of Income for the Three- Month Periods
Ended March
31, 2008 and 2007
|
2
|
|
Condensed
Consolidated Statements of Cash Flows for the Three- Month Periods
Ended
March 31, 2008 and 2007
|
3
|
|
Notes
to Condensed Consolidated Financial Statements
|
4
|
|
Item
2.
|
Management’s
Discussion and Analysis of Financial
Condition and Results of Operations
|
13
|
Item
3.
|
Quantitative
and Qualitative Disclosures about Market Risk
|
15
|
Item
4.
|
Controls
and Procedures
|
15
|
PART
II.
|
OTHER
INFORMATION
|
|
Item
1.
|
Legal
Proceedings
|
16
|
Item
2.
|
Unregistered
Sales of Equity Securities and Use of Proceeds
|
16
|
Item
3.
|
Defaults
upon Senior Securities
|
16
|
Item
4.
|
Submission
of Matters to a Vote of Security Holders
|
16
|
Item
5.
|
Other
Information
|
16
|
Item
6.
|
Exhibits
|
16
|
SIGNATURES
|
17
|
March
31,
2008
|
December
31, 2007
|
||||||
(Unaudited)
|
(Note
B)
|
||||||
Assets
|
|||||||
Current
assets:
|
|||||||
Cash
and cash equivalents
|
$
|
34,568
|
$
|
30,473
|
|||
Short-term
investments
|
-
|
1,998
|
|||||
Accounts
receivable, net of allowances for doubtful accounts of $150
|
24,780
|
31,856
|
|||||
Inventories
|
273
|
186
|
|||||
Deferred
income taxes
|
1,053
|
1,589
|
|||||
Prepaid
expenses and other current assets
|
1,172
|
1,761
|
|||||
Total
current assets
|
61,846
|
67,863
|
|||||
Equipment,
net of accumulated depreciation of $10,731 and $10,091,
respectively
|
13,408
|
11,302
|
|||||
Goodwill
|
2,119
|
2,119
|
|||||
Other
intangible assets, net of accumulated amortization of $1,347 and
$1,320,
respectively
|
1,075
|
1,088
|
|||||
Deferred
income taxes
|
2,913
|
2,552
|
|||||
Other
assets
|
2,704
|
2,290
|
|||||
Total
assets
|
$
|
84,065
|
$
|
87,214
|
|||
Liabilities
and Shareholders’ Equity
|
|||||||
Current
liabilities:
|
|||||||
Short-term
debt
|
$
|
2,136
|
$
|
2,051
|
|||
Accounts
payable
|
9,966
|
13,632
|
|||||
Accrued
liabilities
|
4,333
|
7,037
|
|||||
Total
current liabilities
|
16,435
|
22,720
|
|||||
Other
liabilities
|
1,300
|
1,255
|
|||||
Total
liabilities
|
17,735
|
23,975
|
|||||
Shareholders'
equity:
|
|||||||
Common
stock, $.01 par value, 40,000,000 shares authorized, 22,446,793
and
22,410,064 shares
issued, respectively
|
224
|
224
|
|||||
Additional
paid-in capital
|
112,826
|
111,459
|
|||||
Accumulated
deficit
|
(47,249
|
)
|
(48,882
|
)
|
|||
Accumulated
other comprehensive income
|
257
|
166
|
|||||
Nil
coupon perpetual loan notes
|
272
|
272
|
|||||
Total
shareholders' equity
|
66,330
|
63,239
|
|||||
Total
liabilities and shareholders' equity
|
$
|
84,065
|
$
|
87,214
|
Three
Months Ended
March
31
|
|||||||
2008
|
2007
|
||||||
Revenues
|
$
|
20,467
|
$
|
16,262
|
|||
Costs
and expenses:
|
|||||||
Cost
of sales
|
10,669
|
8,957
|
|||||
Selling,
general and administrative
|
6,979
|
5,906
|
|||||
Research
and development
|
555
|
554
|
|||||
18,203
|
15,417
|
||||||
Operating
income
|
2,264
|
845
|
|||||
Interest
expense
|
(46
|
)
|
-
|
||||
Interest
income
|
276
|
417
|
|||||
Other
income (expense)
|
136
|
(41
|
)
|
||||
Income
before taxes
|
2,630
|
1,221
|
|||||
Income
tax
|
(997
|
)
|
(429
|
)
|
|||
Net
income
|
$
|
1,633
|
$
|
792
|
|||
Net
income per Common Share:
|
|||||||
Basic
|
$
|
0.07
|
$
|
0.04
|
|||
Diluted
|
$
|
0.07
|
$
|
0.03
|
|||
Weighted-average
number of Common Shares outstanding:
|
|||||||
Basic
|
22,420,000
|
22,107,000
|
|||||
Diluted
|
24,567,000
|
24,653,000
|
Three
Months Ended
March
31
|
|||||||
2008
|
2007
|
||||||
Operating
activities
|
|||||||
Net
cash provided by (used in) operating activities
|
$
|
4,416
|
$
|
(1,342
|
)
|
||
Investing
activities
|
|||||||
Sales
of short-term investments
|
1,998
|
8,000
|
|||||
Purchases
of equipment and patents
|
(2,761
|
)
|
(697
|
)
|
|||
Net
cash (used in) provided by investing activities
|
(763
|
)
|
7,303
|
||||
Financing
activities
|
|||||||
Proceeds
from short-term borrowings
|
85
|
-
|
|||||
Issuance
of deferred shares
|
15
|
-
|
|||||
Proceeds
from exercise of stock options and warrants
|
88
|
506
|
|||||
Excess
tax benefit for stock-based compensation
|
163
|
727
|
|||||
Net
cash provided by financing activities
|
351
|
1,233
|
|||||
Effect
of exchange rate fluctuations on cash
|
91
|
3
|
|||||
Net
increase in cash and cash equivalents
|
4,095
|
7,197
|
|||||
Cash
and cash equivalents at beginning of period
|
30,473
|
24,405
|
|||||
Cash
and cash equivalents at end of period
|
$
|
34,568
|
$
|
31,602
|
Three
Months Ended March 31
|
|||||||
2008
|
2007
|
||||||
Basic
weighted-average shares
|
22,420,000
|
22,107,000
|
|||||
Conversion
of unsecured loan notes
|
45,000
|
45,000
|
|||||
Unexercised
options and warrants
|
2,102,000
|
2,501,000
|
|||||
Diluted
weighted-average shares
|
24,567,000
|
24,653,000
|
Three
Months Ended March 31
|
|||||||
2008
|
2007
|
||||||
Comprehensive
income:
|
|||||||
Net
income
|
$
|
1,633
|
$
|
792
|
|||
Foreign
currency translation
|
91
|
3
|
|||||
$
|
1,724
|
$
|
795
|
2008
|
2007
|
||||||
Expected
dividend yield
|
0.00
|
%
|
0.00
|
%
|
|||
Risk-free
interest rate
|
2.80
|
%
|
4.46
|
%
|
|||
Expected
volatility
|
58.4
|
%
|
56.8
|
%
|
|||
Expected
life of option
|
5.2
years
|
5.2
years
|
Number
of Options |
Weighted-
Average
Exercise
Price |
Weighted-
Average Remaining Contractual Term |
Aggregate
Intrinsic Value |
||||||||||
Outstanding
on January 1, 2008
|
2,464,325
|
$
|
15.03
|
||||||||||
Granted
|
464,500
|
17.82
|
|||||||||||
Exercised
|
(36,275
|
)
|
3.07
|
$
|
553
|
||||||||
Expired
or forfeited
|
(15,000
|
)
|
24.06
|
||||||||||
Outstanding
on March 31, 2008
|
2,877,550
|
$
|
15.58
|
7.89
years
|
$
|
18,711
|
|||||||
Exercisable
on March 31, 2008
|
1,001,425
|
$
|
7.55
|
6.13
years
|
$
|
12,966
|
|||||||
Weighted-average
fair value of options granted during first three months of
2008
|
$
|
9.45
|
Nonvested Stock
Outstanding
|
||||
Outstanding
on January 1, 2008
|
1,508,500
|
|||
Granted
|
464,500
|
|||
Released
|
(81,875
|
)
|
||
Expired
or forfeited
|
(15,000
|
)
|
||
Outstanding
on March 31, 2008
|
1,876,125
|
Three
months ended
March
31, 2008
|
Nitrogen Oxide
Reduction |
Fuel Treatment
Chemical |
Other
|
Total
|
|||||||||
Revenues
from external customers
|
$
|
11,669
|
$
|
8,798
|
$
|
-
|
$
|
20,467
|
|||||
Cost
of sales
|
6,145
|
4,524
|
-
|
10,669
|
|||||||||
Gross
margin
|
5,524
|
4,274
|
-
|
9,798
|
|||||||||
Selling,
general and administrative
|
-
|
-
|
6,979
|
6,979
|
|||||||||
Research
and development
|
-
|
-
|
555
|
555
|
|||||||||
Operating
income (loss)
|
$
|
5,524
|
$
|
4,274
|
$
|
(7,534
|
)
|
$
|
2,264
|
Three
months ended
March
31, 2007
|
Nitrogen Oxide
Reduction |
Fuel Treatment
Chemical |
Other
|
Total
|
|||||||||
Revenues
from external customers
|
$
|
8,609
|
$
|
7,653
|
$
|
-
|
$
|
16,262
|
|||||
Cost
of sales
|
5,027
|
3,895
|
35
|
8,957
|
|||||||||
Gross
margin
|
3,582
|
3,758
|
(35
|
)
|
7,305
|
||||||||
Selling,
general and administrative
|
-
|
-
|
5,906
|
5,906
|
|||||||||
Research
and development
|
-
|
-
|
554
|
554
|
|||||||||
Operating
income (loss)
|
$
|
3,582
|
$
|
3,758
|
$
|
(6,495
|
)
|
$
|
845
|
Three
months ended March 31
|
|||||||
2008
|
2007
|
||||||
Revenues:
|
|||||||
United
States
|
$
|
19,084
|
$
|
14,007
|
|||
Foreign
|
1,383
|
2,255
|
|||||
$
|
20,467
|
$
|
16,262
|
|
March
31,
2008
|
December 31,
2007
|
|||||
Assets:
|
|||||||
United
States
|
$
|
76,289
|
$
|
79,132
|
|||
Foreign
|
7,776
|
8,082
|
|||||
$
|
84,065
|
$
|
87,214
|
2008
|
||||
Aggregate
product warranty liability at January 1, 2008
|
$
|
464
|
||
Aggregate
accruals related to product warranties
|
-
|
|||
Aggregate
reductions for payments
|
(26
|
)
|
||
Aggregate
product warranty liability at March 31, 2008
|
$
|
438
|
·
|
Level
1 – Unadjusted quoted prices in active markets that are accessible at
the measurement date for identical, unrestricted assets or
liabilities.
|
·
|
Level
2 – Inputs other than quoted prices included within Level 1 that are
observable for the asset or liability, either directly or indirectly,
including quoted prices for similar assets or liabilities in active
markets; quoted prices for identical or similar assets or liabilities
in
markets that are not active; inputs other than quoted prices that are
observable for the asset or liability (e.g., interest rates); and
inputs
that are derived principally from or corroborated by observable market
data by correlation or other means.
|
·
|
Level
3 – Inputs that are both significant to the fair value measurement and
unobservable.
|
Date:
May 6, 2008
|
By:
|
/s/
John F. Norris Jr.
|
John
F. Norris Jr.
|
||
Director, President and Chief Executive Officer
|
||
Date:
May 6, 2008
|
By:
|
/s/
Vincent J. Arnone
|
Vincent
J. Arnone
|
||
Chief
Financial Officer,
|
||
Sr.
Vice President and
|
||
Treasurer
|